Antileishmanial activity of a guaianolide from Tanacetum parthenium (L.) Schultz Bip

Parasitology International

Volumn 59, Issue 4, 2010, Pages 643-646

  da Silva, Bruna Polacchine ^a   Cortez, Diogenes Aparício ^a   Violin, Thaisa Yume ^a   Filho, Benedito Prado Dias ^a   Nakamura, Celso Vataru ^a   Ueda Nakamura, Tânia ^a   Ferreira, Izabel Cristina Piloto ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antileishmanial activity; Guaianolide; Leishmania amazonensis; Tanacetum parthenium

Indexed keywords

ALCOHOL DERIVATIVE; TANACETUM PARTHENIUM EXTRACT;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; FLAGELLUM; GROWTH INHIBITION; IC 50; LEISHMANIA; MACROPHAGE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SCANNING ELECTRON MICROSCOPY; SURVIVAL;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; HUMANS; LEISHMANIA; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; PARASITIC SENSITIVITY TESTS; PLANT EXTRACTS; SESQUITERPENES, GUAIANE; TANACETUM PARTHENIUM;

LEISHMANIA AMAZONENSIS; MAMMALIA; PROTOZOA; TANACETUM PARTHENIUM;

EID: 77958461780     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2010.08.005     Document Type: Article

References (11)

1. Almeida M.C., Vilhena V., Barral A., Barral-Netto M. Leishmanial infection: analysis of its first steps. A review. Mem Inst Oswaldo Cruz 2003, 98:861-870.
2. Coelho A.C., Gentil L.G., Silveira J.F., Cotrim P.C. Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine. Exp Parasitol 2008, 120:98-102.
3. Alnaim L., Alsoud N.A., Zaghioul I., Al-Jaser M. Effects of fluconazole on the pharmacokinetics and pharmacodynamics of antimony in cutaneous leishmaniasis-infected hamsters. Int J Antimicrob Agents 2007, 29:728-732.
4. Davis A.J., Murray H.W., Handman E. Drugs against leishmaniasis: a synergy of technology and partnerships. Trends Parasitol 2004, 20:73-76.
5. Croft S.L., Seifert K., Yarddley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006, 123:399-410.
6. Scotti M.T., Fernandes M.B., Ferreira M.J.P., Emerecenciano V.P. Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity. Bioorg Med Chem 2007, 15:2927-2934.
7. Tiuman T.S., Ueda-Nakamura T., Cortez D.A.G., Filho B.P.D., Morgado-Díaz J.A., Souza W., et al. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agents Chemother 2005, 49:176-182.
8. Castañeda-Acosta J., Fischer N.H., Vargas D. Biomimetic transformations of parthenolide. J Nat Prod 1993, 56:90-98.
9. Neukirch H., Kaneider N.C., Wiedermann C.J., Guerriero A., D'Ambrosio M. Parthenolide and its photochemically synthesized 1(10) Z isomer: chemical reactivity and structure-activity relationship studies in human leucocyte chemotaxis. Bioorg Med Chem 2003, 11:1503-1510.
10. Shall A., Reiser O. Synthesis of biologically active guaianolides with a trans-annulated lactone moiety. Eur J Org Chem 2008, 2353-2364.
11. Bruno M., Rosselli S., Maggio A., Raccuglia R.A., Bastow K.F., Lee K. Cytotoxic activity of some natural and synthetic guaianolides. J Nat Prod 2005, 68:1042-1046.